Open access · US-GOV via ClinicalTrials.gov Clinical trial

Safety and Efficacy of Subretinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Age-related Macular Degeneration Diseases

Authors not listed

Chinese Academy of Sciences · 2018

Stem-cell exhaustion Human Randomized controlled trial

Abstract

This project intends to transplant human embryonic stem cells derived retinal pigment epitheliums into subretinal space of patients to treat dry age-related macular degeneration(dry-AMD).And we will assess the safety and efficacy of RPE transplants to treat dry AMD.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-26 MST

Cite this

APA

Anonymous. (2018). Safety and Efficacy of Subretinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Age-related Macular Degeneration Diseases. <em>Chinese Academy of Sciences</em>. https://clinicaltrials.gov/study/NCT02755428

Vancouver

Anonymous. Safety and Efficacy of Subretinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Age-related Macular Degeneration Diseases. Chinese Academy of Sciences. 2018.

BibTeX

@misc{anon2018Safety, title = {Safety and Efficacy of Subretinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Age-related Macular Degeneration Diseases}, author = {Anonymous}, journal = {Chinese Academy of Sciences}, year = {2018}, }